Aspirin, a Potential GLUT1 Inhibitor in a Vascular Endothelial Cell Line.

Hu, Yabo; Lou, Xiaohan; Wang, Ruirui; Sun, Chanjun; Liu, Xiaomeng; Liu, Shuochuan; Wang, Zibing; Ni, Chen

Hu, Yabo; Lou, Xiaohan; Wang, Ruirui; Sun, Chanjun; Liu, Xiaomeng; Liu, Shuochuan; Wang, Zibing; Ni, Chen.

Afiliação

Hu Y; Department of Immunotherapy, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450000, Henan, P.R.China.
Lou X; Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, P.R.China.
Wang R; Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, P.R.China.
Sun C; Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, P.R.China.
Liu X; Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, P.R.China.
Liu S; Nanchang University Queen Mary School, Nanchang 330000, P.R.China.
Wang Z; Department of Immunotherapy, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450000, Henan, P.R.China.
Ni C; Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, P.R.China.

Open Med (Wars) ; 14: 552-560, 2019.

Article em En | MEDLINE | ID: mdl-31565672

Palavras-chave

Aspirin (ASA); Endothelial cells (ECs); Glucose metabolism; Glucose transporter 1 (GLUT1)

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Open Med (Wars) Ano de publicação: 2019 Tipo de documento: Article